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Introduction
Staphylococcus aureus osteomyelitis is the greatest concern in patient care among orthopedic surgeons as this pathogen causes from 50 to 70% of adult osteomyelitis [1-4]. The increasing incidence of antimicrobial resistant isolates and the morbidity of this type of infection denote that alternative therapeutic approaches are required [5] [6] [7] [8] . In addition, the ability of S. aureus to be internalized by osteoblasts [9] and to form biofilms [10] may lead to persistence and refractory behavior to antibiotic treatment regardless of antibiotic susceptibility in vitro [2] . The skeleton is a dynamic organ system which is constantly being rejuvenated and remodeled [11] . Osteoblasts are responsible for the deposition, calcification and mineralization of bone matrix whereas osteoclasts conduct bone resorption by acidification and release of lysosomal enzymes. The entry of S. aureus to the healthy bone leads to the development of osteomyelitis, which results in disruption of the fine balance between osteoblast and osteoclast activity [2,12,13].
Many S. aureus virulence factors have been suggested to play a role in the pathogenesis of bone infections [2] . We have previously identified protein A as a major inducer of inflammatory responses due to its ability to activate host cell signaling cascades by interacting with the TNF receptor 1 (TNFR1) and the EGF receptor (EGFR) [14] [15] [16] [17] . Several studies have recently demonstrated the role of protein A-TNFR1 interaction in the production of soluble mediators by pre-osteoblasts [18] as well as the induction of osteoblast apoptosis, decreased proliferation and mineralization [19] and increased Receptor Activator for Nuclear Factor κ B Ligand (RANKL) secretion [20] , suggesting a role for this protein in negative modulation of bone deposition. The action differentiate into osteoclast precursors [25] which were stimulated in the presence of M-CSF (30 ng/ml). Every 2-3 days, the culture media and all stimuli were replaced. Cells were fixed in 4% paraformaldehyde and stained for Tartrate-Resistant Acid Phosphatase (TRAP) (Sigma-Aldrich, St. Louis, MO, USA). Multinucleated (more than three nuclei),
TRAP-positive cells were defined as osteoclasts. MMP-9 activity in supernatants was assayed as described previously [26] and the levels of mouse and human TNF-α as well as mouse MMP-9 were quantified using commercially available ELISA kits [R&D Systems (mouse TNF-α and MMP-9), BD Biosciences (human TNF-α)].
Pit formation assay
Bone marrow cells from C57BL/6 or tnfr1 -/-mice (2x10 5 cells/well in 0.2 ml of media) were plated on dentine disks (BD BioCoat Osteologic, BD Biosciences, San Diego, CA, USA), differentiated into osteoclast precursors as described above and subsequently cultured in complete medium containing 1x10 8 CFU/ml of heat-killed bacteria in the presence of M-CSF (30 ng/ml) for 9 days. Media and all reagents were replaced daily. Dentine discs were washed with 1M NH 4 OH to remove adherent cells,
rinsed with water and resorption lacunae were visualized by light microscopy. Digital images of representative fields for each well were taken. The assay was run in duplicated wells.
Real-time Polymerase Chain Reaction
RNA was isolated using TRIzol Reagent (Invitrogen). Complementary DNA was made from 1 μg of RNA using M-MLV Reverse Transcriptase (Promega). The following primers were used for amplification: mouse RANK: 5'-TGTGGTCTGCAGCTCTTCCA-3'
and 5'-CGAAGATGATGGCAGCCACTA-3', annealing: 58ºC; mouse Cathepsin K: 5'-GAGGGCCAACTCAAGAAGAA-3' and 5'-GCCGTGGCGTTATACATACA-3', annealing:
50ºC; mouse GAPDH: 5′-GAAGGTGGTGAAGCAGGCAT-3′ and 5′-TCGAAGGTGGAAGAGTGGGA-3′, annealing: 60ºC. Forty cycles were run with denaturation at 95°C for 15 seconds, the corresponding annealing temperature for each gene for 30 seconds and extension at 60°C for 30 seconds. Glyceraldehyde 3-phosphate dehydrogenase (mGAPDH) was used as control for standardization.
Mouse and rat osteomyelitis models
BALB/c mice or Wistar rats (10 weeks old) were anesthetized with ketamine/xylazine, the left tibia was exposed, and a hole in the bone was made with a high-speed drill using a 1 mm diameter bit. The tibia was inoculated with 5 µl (rat) or 2.5 µl (mouse) of a suspension containing 1-2 x10 6 CFU of S. aureus FPR3757, the isogenic SpA-mutant or PBS as control. The different inocula were suspended in fibrin glue (Tissucol kit 1 ml; Baxter Argentina-AG, Vienna, Austria) [27] . At 48 hours after
inoculation bone marrow cells from infected tibias were obtained to be used in osteoclastogenesis assays. In parallel experiments, 14 days after inoculation the tibias were subjected to micro-CT analysis. Left and right tibias from rats were excised and evaluated morphometrically, and the osteomyelitic index (OI) was determined as described previously [28] . Briefly, the following measurements were made using calipers: (i) the distance between the inoculation point and the distal end of the left tibia (DT); (ii) the left tibia section diameter at the inoculation site (Di) and the perpendicular diameter at the same site (Dp); (iii) Di and Dp were also measured in the uninfected right tibia of the same rat at the DT determined in the diseased left tibia (control). The osteomyelitic index (OI) was determined as follows: OI = (Dp +Di) infected -(Dp +Di)
control. To assess the bacterial load, the infected bones were crushed, homogenized in sterile mortars and quantitatively cultured on TSA plates.
Histopathological and osteoclast evaluation during in vivo infection
Tibias were fixed overnight in 4% paraformaldehyde, followed by decalcification in 10% EDTA in 1 mM TrisHCl (pH 7.4) for 2 weeks at 4°C, dehydrated in ethanol at 96 and 100%, clarified in xylene, and routinely embedded in paraffin. Haematoxylin-eosin and TRAP staining were performed on tissue sections.
Microcomputed Tomography (micro-CT)
Analysis of cortical bone destruction was determined by micro-CT imaging with a μCT50 (Scanco Medical) and the manufacturer's analytical software as previously described [29] . Briefly, axial images of each tibia were acquired with 5.0 mmvoxels at 70 
S. aureus protein A induces osteoclastogenesis
First, we established the potential role of S. aureus protein A in driving osteoclast differentiation. A significant increase in the number of osteoclasts was observed in response to protein A compared with cells stimulated with GST or media alone as control (Fig. 1A) . In order to evaluate the osteoclastogenic potential of protein A in the context of the bacterial cell wall, we used the Lactococcus lactis heterologous expression system. A significant increase in the number of osteoclasts was induced by L. lactis SpA (Fig. 1B ) and this response was significantly inhibited by an anti-protein A neutralizing antibody (Fig. 1B) . Considering that bacteria-host interactions may vary among different hosts the role of SpA in the induction of osteoclastogenesis was further confirmed using osteoclast precursors from C57BL/6 mice ( Fig. 1B) .
We then determined the contribution of protein A-mediated osteoclastogenesis to overall S. aureus-induced osteoclast differentiation. A significant number of osteoclasts were observed after stimulation of osteoclast precursors with S. aureus (Fig. 1C) . A significant role for protein A in this process was demonstrated by using an isogenic mutant lacking protein A expression (SpA-) (Fig. 1C) . Moreover, osteoclast differentiation induced by S. aureus was significantly decreased in the presence of an anti-protein A neutralizing antibody (Fig. 1C ).
Considering that Staphylococcus aureus is a major cause of osteomyelitis in humans, experiments using human monocytes as osteoclast precursors were also conducted. A significant increase in the number of osteoclasts was observed in
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11 response to S. aureus (Fig. 1D) , and protein A significantly contributed to osteoclast differentiation as demonstrated using the isogenic SpA-mutant (Fig. 1D ). These observations were further confirmed by stimulating the cells with L. lactis SpA (Fig. 1D ).
Since TNF-α may significantly contribute to osteoclast differentiation [13, 21] , we determined the induction of this inflammatory cytokine in precursors from BALB/c mice.
S. aureus induced an early increase in TNF-α and the levels of this cytokine were significantly lower in response to the SpA-mutant as well as in cells stimulated with S.
aureus in the presence of the anti-protein A neutralizing antibody ( Fig. 2A) . Moreover, L.
lactis SpA induced significant levels of TNF-α (Fig. 2B ). Similar results were observed using C57BL/6 mice ( Fig. 2C and D). TNF-α was also induced in human monocytes in response to S. aureus (Fig. 2E ) or L. lactis SpA (Fig. 2F ) and the levels of this cytokine were significantly lower in response to the SpA-mutant (Fig. 2E ).
Osteoclastogenesis induced by protein A is mediated by TNFR1 and EGFR
In order to establish the signaling pathways involved in protein A-induced osteoclastogenesis the role of TNFR1 and EGFR, both previously shown to be involved in protein A signaling in several cell types [14, 17, 19, 20] was investigated. A significant decrease in the number of osteoclasts derived from precursor cells in response to L.
Lactis SpA and protein A was observed using progenitors from tnfr1 -/-mice as compared to C57BL/6 mice ( Fig. 3A) . TNF-α and RANKL were used as positive controls. The absence of baseline deficits in osteoclast precursors from tnfr1 -/-mice was demonstrated using RANKL as stimuli (Fig. 3A) . We then evaluated the contribution of EGFR by using a mutated protein A (SpAL17A) that is not able to signal through this receptor [17] . A
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12 significant decrease in osteoclastogenesis was observed in cells from C57BL/6 mice stimulated with the SpAL17A protein compared with that observed in response to the wild type SpA-D (Fig. 3B) . Moreover, when osteoclast precursors from tnfr1 -/-mice were stimulated with SpAL17A, the osteoclastogenesis was equivalent to that observed in control cells (Fig. 3B ). Taken together these results demonstrate that protein A induces osteoclastogenesis by activating TNF and EGF receptors in osteoclast precursors.
As we previously showed that protein A induces early TNF-α production ( Fig. 2) , we then evaluated whether protein A was able to induce osteoclastogenesis through direct TNFR1 activation or the signaling was secondary to TNF-α production. A significant decrease in osteoclastogenesis was observed when cells from C57BL/6 mice were stimulated with SpA-D in the presence of an anti-TNF-α neutralizing antibody ( We then evaluated the role of TNF-α in the osteoclastogenesis induced by S.
aureus. A significant reduction in the number of osteoclasts was observed when cells from tnfr1 -/-mice were stimulated with S. aureus (Fig. 3D ). The number of osteoclasts differentiated from tnfr1 -/-precursors in response to the protein A deficient mutant was decreased compared with the differentiation observed in osteoclast precursors from C57Bl/6 mice ( Fig. 3D) , suggesting that other molecules in addition to SpA induce TNF-α responses critical for osteoclastogenesis. This was further confirmed in osteoclast
precursors from C57Bl/6 mice stimulated with the SpA-mutant in the presence of an anti-TNF-α antibody (Fig. 3D) .
Protein A and TNFR1 signaling are critical for osteoclast activity
The most important proteinases involved in organic bone matrix degradation are cathepsin K and MMP-9 [30, 31] . Therefore, we quantified the levels of cathepsin K expression and found that it was significantly increased in osteoclasts differentiated in response to S. aureus or L.lactis SpA (Fig. 4A) . Conversely, the SpA-mutant induced significantly lower levels of cathepsin K expression (Fig. 4A ). Induction of cathepsin K was not observed in osteoclast precursors from tnfr1 -/-mice (Fig. 4A ). In addition, increased levels of MMP-9 were observed in the supernatants of cells stimulated with S.
aureus compared with those found in the supernatants of cells stimulated with the SpAmutant (Fig. 4B ). The differences in MMP-9 expression correlated with increased gelatinase activity induced by S. aureus, which according to the molecular weight of the band corresponded to MMP-9, compared with that induced by the SpA-mutant (Fig.   4C ). MMP-9 expression and activity was decreased in supernatants from cells stimulated with S. aureus in the presence of an anti-protein A neutralizing antibody ( Fig.   4B and C).
The ability of osteoclasts differentiated in response to S. aureus to resorb dentine was determined as an indicator of its functionality. Osteoclast precursors from C57BL/6 mice stimulated with S. aureus or L. lactis SpA were able to resorb dentine whereas cells stimulated with the SpA-mutant or L. lactis CV did not form resorption pits (Fig.   4C ). These results indicate that whereas other staphylococcal antigens besides protein
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A may induce osteoclast differentiation as evidenced using the SpA-mutant ( Fig.1 and Fig. 3 ), protein A is critical for the induction of osteoclast activity (Fig. 4C ). In addition, TNFR1 signaling also proved critical for osteoclast activity as demonstrated by the lack of dentine resorption pits when cells from tnfr1 -/-mice were used as osteoclast precursors (Fig. 4C) .
S. aureus protein A contributes to bone damage during experimental osteomyelitis.
The role of protein A in bone damage during staphylococcal infection was evaluated using previously described animal models [28, 29] . In order to assess the early impact of protein A expression on osteoclast differentiation during in vivo infection, we first determined the ability of S. aureus and the SpA-mutant to prime osteoclast precursors. Bone marrow cells from mice previously inoculated with S. aureus showed significantly increased ability to differentiate into mature osteoclasts in response to RANKL than those obtained from mice inoculated with the SpA-mutant (Fig. 5A) .
Moreover, the osteoclastogenic potential of cells from mice inoculated with the SpAmutant did not differ from cells obtained from control mice inoculated with PBS highlighting the importance of protein A in the early priming of osteoclast precursors (Fig. 5A) . The decreased priming in cells from SpA-inoculated mice was not due to differences in the amount of bacteria present in the bone as assessed by bacterial count in bone homogenates (Fig. 5B) . In order to determine the consequences of the increased osteoclastogenic activity during S. aureus infection, cortical bone destruction was quantified by micro-CT 14 days after inoculation as previously described [29] . A significant increase in bone destruction was observed in the tibias from mice inoculated A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 15 with S. aureus compared with that quantified in mice inoculated with PBS ( Fig. 5C and   D ; Movie S1 and S2 ). Conversely, cortical bone loss in the tibias from mice inoculated with the SpA-mutant was nearly equivalent to that observed in mice inoculated with PBS as control ( Fig. 5C and D ; Movie S1 and S3). At 14 days after challenge, no significant differences in the bacterial load of the bones were observed between the S.
aureus and the SpA-inoculated mice (Fig. 5E ).
Using the rat osteomyelitis model [28] MMP-9 activity in bone homogenates was evaluated as an indicator of the presence of functional osteoclasts. Increased gelatinase activity was detected in bone from rats inoculated with S. aureus whereas no increase in MMP-9 activity was observed in bone from rats inoculated with the SpA-mutant (Fig.   6A ). A significant macroscopic enlargement of the bone at the inoculation site of the tibia, represented as the osteomyelitic index, was observed at 15 weeks after challenge and the osteomyelitic index was significantly lower in tibia from rats inoculated with the SpA-mutant (Fig. 6B ). Histopathological analysis of tibia sections from infected rats at 96 hours post-challenge revealed only congestion and a mild neutrophil exudate at the site of inoculation in all groups (data not shown). After 15 weeks, rats inoculated with the SpA-mutant showed no histological changes indicative of acute inflammation (Fig. 6C) , whereas those inoculated with S. aureus developed lesions characterized by edema, congestion and intense neutrophil infiltrates in the bone marrow as well as fragments of detached, dead bone (sequestra) surrounded by pockets of pus (Fig. 6C) . Increased osteoclastogenesis during in vivo S. aureus infection was also evidenced by the presence of TRAP positive multinucleated cells in tibia sections (Fig. 6C) . Conversely, multinucleated TRAP positive cells were not observed in tibia sections from rats
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16 inoculated with the SpA-mutant (Fig. 6C) further confirming that the presence of protein A is critical for bacterial-induced osteoclastogenesis in vivo. At this time point, 15 weeks after the onset of infection, a significant decrease in bacterial counts in the bones of rats inoculated with the SpA-mutant was observed (Fig. 6D) . The differential clearance could be partially explained by the reduced amount of potential niches for bacterial persistence in the bones inoculated with the mutant compared with those inoculated with S. aureus in which sequestra are observed. In addition, the known ability of protein A to inhibit opsonophagocytosis could contribute to enhanced bacterial clearance at a time point in which specific antibodies are likely to be present.
Discussion
Although the importance of S. aureus as a causative agent of osteomyelitis is widely recognized, the molecular events that take place during the interaction of this pathogen with host cells within the bone microenvironment are certainly not completely understood. It has been established that the fine regulation of the osteoblast and osteoclast crosstalk is critical for bone physiology, and pro-inflammatory cytokines disrupt the balance between the activities of these two cell types [13] . In order to understand the molecular basis of bone damage during osteomyelitis, a great deal of attention has been given to the interaction of S. aureus with osteoblasts and it was suggested that osteoblasts would interpret the majority of the extracellular signals and subsequently modulate osteoclast differentiation and function via RANKL (2, 19, 20, 27, 28) . Current experimental evidence also demonstrates that osteoclast precursors are able to sense different stimula [25, [34] [35] [36] . Recent studies using live bacteria
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17 demonstrated that S. aureus modulates cytokine production in osteoclast precursors and increases the resorption activity of mature osteoclasts in the absence of osteoblasts [37] . Considering the ability of S. aureus protein A to signal through TNFR1 and EGFR, in this study we investigated the role of this staphylococcal surface protein in modulating osteoclastogenesis. We demonstrated that protein A plays a critical role in osteoclast differentiation and activation in vitro using murine bone marrow cells and human monocytes primed with M-CSF as osteoclast precursors. Moreover, protein A significantly contributed to increased osteoclast differentiation and activation as well as cortical bone destruction during the course of disease in two experimental models of osteomyelitis.
Using tnfr1 -/-deficient mice and a mutated SpA that cannot signal through EGFR, we demonstrated that the ability of protein A to induce osteoclastogenesis was mediated by TNFR1 and EGFR signaling. The role of TNF-α in the induction of osteoclastogenesis has been previously demonstrated [22] . S. aureus and protein A induced the early production of this cytokine, suggesting that either TNF-α could be responsible for the osteoclastogenesis or that protein A could directly induce osteoclast differentiation due to its ability to signal through TNFR1 and activate NF-κB [14, 18] . The use of an anti-TNF-α neutralizing antibody allowed us to determine that osteoclastogenesis was indeed secondary to TNF-α. This cytokine is probably produced as a consequence of the initial interaction of protein A with TNFR1 [16, 20] . The role of EGFR in osteoclast formation and distribution along the bone has been previously demonstrated using egfr -/-embryos [38] . Moreover, in vitro assays have further established that EGFR is a critical regulator of osteoclast differentiation and survival through cross-talk with RANK signaling.
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RANKL-RANK interaction trans-activates EGFR and induces its phosphorylation which
is critical for osteoclast differentiation [38, 39] . We have previously demonstrated the ability of protein A to induce EGFR phosphorylation and activation of downstream signaling [17] which may explain the role of EGFR in the osteoclastogenesis induced by this protein. An interesting finding of this study was that although the osteoclast differentiation induced by protein A was dependent on both receptors, the osteoclast activity was completely abolished in the absence of TNFR1 signaling. In this regard, previous work using RANKL as a trans-activator of EGFR has demonstrated that the osteoclast resorptive activity is not modulated by EGFR signaling [38] indicating that different signals control osteoclast differentiation and their function. Our findings are in agreement with a previous study demonstrating a critical role for TNFR1 in LPS/TNF-α mediated osteoclastogenesis [40] .
Our results also demonstrate that other staphylococcal molecules, in addition to protein A, induce osteoclastogenesis [41] . This is likely through the induction of TNF-α based on the results of experiments using the anti-TNF-α neutralizing antibody and the SpA-mutant as stimuli. It has been demonstrated that surface-associated material from S. aureus, mostly constituted by proteins, is able to stimulate osteoclast maturation and activation in the absence of exogenously added RANKL [34, 42] and the differentiation is inhibited in the presence of anti-TNF-α antibodies [34] . A role for S. aureus lipoproteins in osteoclast differentiation has also been recently described [43] . The staphylococcal surface protein Sbi has been recently identified as a novel inducer of TNFR1 and EGFR signaling in macrophages [44] and could potentially contribute to the osteoclastogenesis induced by S. aureus. An intriguing finding of this study, was that although the SpA-
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19 mutant induced osteoclast differentiation through the induction of TNF-α by other bacterial molecules, it did not induce resorption pit formation suggesting that the signals that drive osteoclast activity are complex and far from being completely elucidated. In this regard, in vivo studies are highly valuable tools that can contribute to a better understanding of the molecular events that lead to bone resorption during osteomyelitis.
Several animal models have been proposed to study the pathogenesis of bacterial osteomyelitis in vivo [45, 46] . Using a modification of a previously described mouse model of experimental osteomyelitis [29] we were able to demonstrate that the presence of protein A has a significant impact in osteoclast differentiation during the initial stages of S. aureus infection. Moreover, micro-CT analysis of the infected bone highlighted the importance of protein A in mediating cortical bone destruction. Our results are in agreement with previous studies demonstrating that sae, a positive regulator of SpA [47] contributes to bone destruction [29] . In addittion, using a rat osteomyelitis model [27, 28] we were able to investigate the biological relevance of our findings during later stages of the disease. Increased number of osteoclasts as well as higher MMP-9 activity in tibias from rats inoculated with S. aureus, as compared with those inoculated with the SpA-mutant demonstrate that protein A contributes not only to osteoclast differentiation but also to osteoclast function in vivo. S. aureus intratibial infection induced histopathological changes that correlated with those previously described during bacterial osteomyelitis. The lack of congestion, edema, neutrophil exudate and bone sequestra in rats inoculated with the SpA-mutant demonstrate the involvement of protein A in the processes that lead to bone destruction during the progression of the disease.
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Given the importance of the regulation of osteoclast activity in the maintenance of proper bone physiology, our data indicate the ability of protein A to drive osteoclast differentiation and activation through TNFR1 signaling which would be particularly relevant during the initial encounter of the host with bacteria contributing to accelerated bone destruction. Taken together, these findings suggest that protein A and TNFR1 could be considered as novel potential prophylactic/therapeutic targets to design agents aimed at preventing bone damage during S. aureus osteomyelitis.
Supplemental material
The following supporting information may be found in the online version of this article:
Movie S1: Cortical bone destruction in a representative tibia of mice inoculated with PBS.
Movie S2: Cortical bone destruction in a representative tibia of mice inoculated with S.
aureus.
Movie S3: Cortical bone destruction in a representative tibia of mice inoculated with the SpA-mutant. osteoclasts was determined by their ability to resorb dentine. Osteoclast precursors from C57BL/6 or tnfr1 -/-mice were cultured on dentine discs and stimulated with S. aureus, the SpA-mutant, L. lactis CV or L. lactis SpA. After 9 days, cells were removed, and dentine resorption pits were determined by light microscopy. Samples were analyzed in a blind manner. 
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
